The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells

Virology

Volumn 383, Issue 1, 2009, Pages 142-149

  Cumming, S A ^a   Chuen Im, T ^a   Zhang, J ^a   Graham, S V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Epithelial differentiation; HPV16; HuR; Late gene expression; Late regulatory element

Indexed keywords

CAPSID PROTEIN; CAPSID PROTEIN L1; HUR PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; UTERINE CERVIX EPITHELIUM;

ANTIGENS, SURFACE; CAPSID PROTEINS; CELL LINE; EPITHELIAL CELLS; FEMALE; GENE DOSAGE; GENE SILENCING; HUMANS; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; RNA STABILITY; RNA, MESSENGER; RNA, VIRAL; RNA-BINDING PROTEINS;

HUMAN PAPILLOMAVIRUS; MIRIDAE;

EID: 57049151268     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.10.003     Document Type: Article

References (44)

1. Abdelmohsen K., Lal A., Kim H.H., and Gorospe M. Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6 (2007) 1288-1292
2. Beyer-Finkler E., Stoler M.H., Girardi F., and Pfister H.J. Cell differentiation-related gene expression of human papillomavirus 33. Med. Microbiol. Immunol. 179 (1990) 185-192
3. Chuen-Im T., Zhang J., Milligan S.G., McPhillips M.G., and Graham S.V. The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element. Virus Res. 131 (2008) 189-198
4. Collier B., Goobar L., Sokolowski M., and Schwartz S. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogeneous ribonucleoprotein K and poly (rC)-binding proteins 1 and 2. J. Biol.Chem. 273 (1998) 22648-22656
5. Collier B., Oberg D., Zhao X., and Schwartz S. Specific inactivation of inhibitory sequences in the 5′ end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J. Virol. 76 (2002) 2739-2752
6. Cumming S.A., and Graham S.V. Analysis of regulatory motifs within HPV transcripts. In: Davy C., and Doorbar J. (Eds). Human Papillomaviruses: Methods and Protocols (2005), Humana Press, Totowa, New Jersey 291-315
7. Cumming S.A., McPhillips M.G., Veerapraditsin T., Milligan S.G., and Graham S.V. Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5′ splice sites that bind a U1 snRNP-like complex. J. Virol. 77 (2003) 5167-5177
8. Dietrich-Goetz W., Kennedy I.M., Levins B., Stanley M.A., and Clements J.B. A cellular 65 kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 163-168
9. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
10. Fan X.C., and Steitz J.A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17 (1998) 3448-3460
11. Fialcowitz-White E.J., Brewer B.Y., Ballin J.D., Willis C.D., Toth E.A., and Wilson G.M. Specific protein domains mediate cooperative assembly of HuR oligomers on AU-rich mRNA-destabilizing sequences. J. Biol. Chem. 283 (2007) 20948-20959
12. Furth P.A., and Baker C.C. An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels. J. Virol. 65 (1991) 5806-5812
13. Furth P.A., Choe W.-T., Rex J.H., Byrne J.C., and Baker C.C. Sequences homologous to 5' splice sites are required for inhibitory activity of papillomavirus late 3' untranslated regions. Mol. Cell. Biol. 14 (1994) 5278-5289
14. Goraczniak R., and Gunderson S.I. The regulatory element in the 3′-untranslated region of human papillomavirus 16 inhibits expression by binding CUG-binding protein 1. J. Biol. Chem. 283 (2008) 2286-2296
15. Graham S.V. Late events in the life cycle of human papillomaviruses. In: Campo M.S. (Ed). Papillomavirus Research: From Natural History to Vaccines and Beyond (2006), Caister Academic Press, Wymondham, Norfolk 193-212
16. Graham S.V. Papillomavirus 3′UTR regulatory elements. Front. Biosci. 13 (2008) 5646-5663
17. Gunderson S.I., Polycarpou-Schwarz M., and Mattaj I.W. U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol. Cell 1 (1998) 255-264
18. Jeon S., Allen-Hoffman B.L., and Lambert P.F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69 (1995) 2989-2997
19. Kawai T., Lal A., Yang X., Galban S., Mazan-Mamczarz K., and Gorospe M. Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR. Mol. Cell. Biol. 26 (2006) 3295-3307
20. Keene J.D. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5-7
21. Kennedy I.M., Haddow J.K., and Clements J.B. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65 (1991) 2093-2097
22. Koffa M.D., Graham S.V., Takagaki Y., Manley J.L., and Clements J.B. The human papillomavirus type 16 negative regulatory element interacts with three proteins that act at different posttranscriptional levels. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4677-4682
23. Levy N.S., Chung S., Furneaux H., and Levy A.P. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273 (1998) 6417-6423
24. Longworth M.S., and Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68 (2004) 362-372
25. López de Silanes I., Lal A., and Gorospe M. Post-transcriptional paths to malignancy. RNA Biol. 2 (2005) e11-e13
26. McPhillips M.G., Veerapraditsin T., Cumming S.A., Karali D., Milligan S.G., Boner W., Morgan I.M., and Graham S.V. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during epithelial differentiation. J. Virol. 78 (2004) 10598-10605
27. Meisner N.-C., Hintersteiner M., Mueller K., Bauer R., Seifert J.-M., Naegeli H.-U., Ottl J., Oberer L., Guenat C., Moss S., Harrer N., Woisetschlaeger M., Buehler C., Uhl V., and Auer M. Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat. Chem. Biol. 3 (2007) 508-515
28. Meyers C., and Laimins L.A. In vitro systems for the study and propagation of human papillomaviruses. Curr. Top. Microbiol. Immunol. 186 (1994) 199-215
29. Milligan S.G., Veerapraditsin T., Ahamat B., Mole S., and Graham S.V. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 360 (2007) 172-181
30. Öberg D., Collier B., Zhao X., and Schwartz S. Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J. Virol. 77 (2003) 11674-11684
31. Peh W.L., Middleton K., Christensen N., Nicholls P., Egawa K., Sotlar K., Brandsma J., Percival A., Lewis J., Liu W.J., and Doorbar J. Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J. Virol. 76 (2002) 10411-10416
32. Peng S.S.-Y., Cehn C.Y.A., Xu N., and Shyu A.-B. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17 (1998) 3461-3470
33. Ruesch M.N., Stubenrauch F., and Laimins L.A. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin. J. Virol. 72 (1998) 5016-5024
34. Sambrook J., Fritsch E., and Maniatis T. "Molecular Cloning: A Laboratory Manual" (1989), Cold Spring Harbour Laboratory Press, Cold Spring Harbour, New York
35. Sokolowski M., Furneaux H., and Schwartz S. The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3′ untranslated region correlates with its affinity for the elav-like HuR protein. J. Virol. 73 (1999) 1080-1091
36. Stanley M.A., Browne H.M., Appelby M., and Minson A.C. Properties of a non-tumourigenic human cervical keratinocyte cell line. Int. J. Cancer 43 (1989) 672-676
37. Stoler M.H., Wolinsky S.M., Whitbeck A., Broker T.R., and Chow L.T. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridisation with message-specific RNA probes. Virology 172 (1989) 331-340
38. Stoler M.H., Rhodes C.R., Whitbeck A., Wolinsky S.M., Chow L.T., and Broker T.R. Human papillomavirus type 16 and 18 gene expression in cervical neoplasia. Human Pathol. 23 (1992) 117-128
39. Tan W., Felber B.K., Zolotukhin A.S., Pavlakis G.N., and Schwartz S. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using rev and the rev-response element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J. Virol. 69 (1995) 5607-5620
40. Wiklund L., Sokolowski M., Carlsson A., Rush M., and Schwartz S. Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich instability element in the HPV-1 late 3′ untranslated region. J. Biol. Chem. 277 (2002) 40462-40471
41. Zhao X., Rush M., and Schwartz S. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J. Virol. 78 (2004) 10888-10905
42. Zhao X., Rush M., Carlsson A., and Schwartz S. The presence of inhibitory RNA elements in the late 3′-untranslated region is a conserved property of human papillomaviruses. Virus Res. 125 (2007) 135-144
43. Zhu H., Hasman R.A., Barron V.A., Luo G., and Lou H. A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators. Mol. Biol. Cell 17 (2006) 5101-5114
44. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev., Cancer 2 (2002) 342-350